Russians miss out on subsidised medication due to lack of awareness
Russians miss out on subsidised medication due to lack of awareness
Russians miss out on subsidised medication due to lack of awareness
Many Russians struggle with the high cost of long-term medication, which can take up a large part of a household’s budget. Government programs offer free or subsidised drugs for certain groups, yet a lack of awareness means some patients still pay full price. Experts now urge people to check if they qualify for financial support on prescriptions. Subsidised medication schemes cover a wide range of people, including veterans, those with disabilities, children with specific conditions, and patients with severe chronic illnesses. However, eligibility often depends on medical need rather than just social status—something not widely understood. A common misconception is that only pensioners or disabled individuals receive free treatment, leaving others unaware of potential savings.
The cost of ongoing therapy can run into thousands of rubles each month, making subsidies a crucial lifeline. Despite this, many still pay out of pocket because they don’t know the programs exist. Regional authorities also run their own discount schemes, but details vary, and patients must stay informed about local changes. Doctors and healthcare experts recommend that patients ask their treating physician about available subsidies. With medication prices rising, interest in these programs has grown in recent years. Yet without proper guidance, some miss out on financial relief they’re entitled to.
Subsidised drug programs can cut medication costs by thousands of rubles per month for eligible patients. To access support, individuals must consult their doctor and keep track of regional updates. Without this, many will continue paying full price for essential treatments.
California judge blocks attempt to expose UCLA's pro-Palestinian event speakers
Free speech wins as a judge halts a campaign to silence Palestinian rights advocates. The decision exposes the dangers of lawfare targeting campus activism.
Vitl's personalised supplements hit Sainsbury's shelves nationwide
From immunity boosts to sleep support, Vitl's science-driven vitamins are now just an aisle away. Could this be the future of personalised wellness?
German nursing care reform faces delay as industry leader demands major revisions
A bold call to halt the reform shakes Berlin. With €1.8 billion at stake and welfare risks looming, will the government rewrite—or rush—ahead?
Stanford's BurgerAI Crafts the Perfect Burger—And It Beats a Big Mac
What if the juiciest, healthiest burger you ever ate was designed by an algorithm? Stanford's AI just proved it's possible—and it's changing fast food forever.